Kalbe Farma Tbk vs PP London Sumatra Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while PP London Sumatra Indonesia Tbk. trades at Rp1,335 (market cap 9.04T, 3.96M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 3.7× PP London Sumatra Indonesia Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 3.96M). Which is the better fit depends on your goals.
| KLBF | LSIP | |
|---|---|---|
Market Cap | 33T | 9.04T |
Volume | 98.44M | 3.96M |
Lot | 984.38K | 39.64K |
Turnover | 70.64B | 5.28B |
Average Price | 717.58 | 1,333.35 |
Value | 70.64B | 5.28B |
Indicative Equilibrium Price | 720 | 1,335 |
Indicative Equilibrium Volume | 43.62K | 139 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Perusahaan Perkebunan London Sumatera Tbk abbreviated as Lonsum, was established in teh Republic of Indonesia based on Notarial Deed No. 93 of Raden Kadiman dated December 18, 1962 and amended by Notarial Deed No. 20 dated September 9, 1963. Based on Notarial Deed No. 18 of Pahala Sutrisno Amijoyo Tampubolon, S.H., M.Kn., dated May 24, 2013, the Company's shareholders approved the change of the Company's status from Foreign Capital Investment (PMA) company to Domestic Capital Investment (PMDN) company.
Read more on LSIP →